Protalix Biotherapeutics Inc (PLX.A)

PLX.A on American Stock Exchange

2.11USD
26 Nov 2014
Price Change (% chg)

$0.01 (+0.48%)
Prev Close
$2.10
Open
$2.08
Day's High
$2.13
Day's Low
$2.06
Volume
23,234
Avg. Vol
55,033
52-wk High
$5.30
52-wk Low
$1.87

PLX.A

Chart for PLX.A

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant... (more)

Overall

Beta: 1.39
Market Cap (Mil.): ₪758.80
Shares Outstanding (Mil.): 93.67
Dividend: --
Yield (%): --

Financials

  PLX.A Industry Sector
P/E (TTM): -- 228.31 39.03
EPS (TTM): -1.35 -- --
ROI: -41.40 -2.22 17.31
ROE: -- -3.38 18.22
Search Stocks

Protalix shares wipe out gains as CEO clarifies Ebola possibilities

JERUSALEM - Shares of Israeli biotech firm Protalix reversed gains on Sunday after the company's chief executive threw cold water on a news report that its technology could be used to develop a version of the Ebola experimental drug ZMapp.

07 Sep 2014

UPDATE 1-Protalix shares wipe out gains as CEO clarifies Ebola possibilities

JERUSALEM, Sept 7 - Shares of Israeli biotech firm Protalix reversed gains on Sunday after the company's chief executive threw cold water on a news report that its technology could be used to develop a version of the Ebola experimental drug ZMapp.

07 Sep 2014

Protalix shares jump on report of possible Ebola drug technology

JERUSALEM, Sept 7 - Shares in Israeli biotech company Protalix jumped on Sunday following a news report that its technology could be used to develop an Ebola treatment similar to the experimental drug ZMapp, which has shown promising results in recent trials.

07 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks